Mücke Thomas, Borgmann Anna, Fichter Andreas M, Wagenpfeil Stefan, Mitchell David A, Ritschl Lucas M, Kesting Marco R, Wolff Klaus-Dietrich
Department of Oral and Maxillofacial Surgery, Technische Universität München, Klinikum Rechts der Isar, Germany.
Br J Oral Maxillofac Surg. 2013 Sep;51(6):555-62. doi: 10.1016/j.bjoms.2012.09.007. Epub 2012 Oct 4.
In this study we investigated the impact of the time at which vascular endothelial growth factor (VEGF) was given on the overall survival of flaps and time of the achievement of full perfusion in the rat epigastric flap model. Epigastric flaps were raised in 144 rats. VEGF was given to 108 rats at different time points. Perioperatively blood flow, velocity, haemoglobin (Hb) concentration, and oxygen saturation were measured non-invasively using laser-Doppler spectrophotometry. On postoperative days 3, 5, 7, or 10, the pedicle of the flap was ligated. One week later, the flap was harvested for immunohistochemical assessment of the density of microvessels. Differences significant from those in the control group were found in all specimens 3 and 5 days after the first operation, whereas no differences in the area of necrosis were detected after 7 and 10 days. Preoperative values of measured Hb (p<0.0001, 95% confidence interval (CI) 0.57 to 1.02), flow (p<0.0001, 95% CI -0.32 to -0.13), and velocity (p<0.0001, 95% CI 0.48 to 1.89) predicted necrosis. After ligation of the pedicle, SO2 (p<0.0001, 95% CI -1.12 to -0.83) and flow (p<0.0001, 95% CI -0.38 to -0.26) were prognostic factors. The topical use of VEGF increases overall survival of flaps and decreases the time needed for a free flap to achieve full perfusion. The time of application of VEGF has no part in the postoperative course. The perfusion of vascularised free flaps in their wound beds was achieved between postoperative days 5 and 7 in the control group and postoperative days 3 and 5 after VEGF had been given.
在本研究中,我们在大鼠腹壁皮瓣模型中,研究了给予血管内皮生长因子(VEGF)的时间对皮瓣总体存活率及完全灌注时间的影响。对144只大鼠掀起腹壁皮瓣。在不同时间点对108只大鼠给予VEGF。围手术期使用激光多普勒分光光度法无创测量血流、流速、血红蛋白(Hb)浓度和血氧饱和度。在术后第3、5、7或10天,结扎皮瓣蒂部。1周后,切取皮瓣进行微血管密度的免疫组化评估。首次手术后3天和5天,所有标本均发现与对照组存在显著差异,而7天和10天后未检测到坏死面积的差异。术前测量的Hb(p<0.0001,95%置信区间(CI)0.57至1.02)、血流(p<0.0001,95%CI -0.32至-0.13)和流速(p<0.0001,95%CI 0.48至1.89)可预测坏死情况。结扎蒂部后,SO2(p<0.0001,95%CI -1.12至-0.83)和血流(p<0.0001,95%CI -0.38至-0.26)是预后因素。局部应用VEGF可提高皮瓣的总体存活率,并缩短游离皮瓣实现完全灌注所需的时间。VEGF的应用时间对术后病程无影响。对照组在术后第5天至第7天实现了带血管游离皮瓣在其创面床的灌注,给予VEGF后在术后第3天至第5天实现了灌注。